Letters: Unwitting savior

Only a total ban on Sanofi and summary dismissal of all those concerned with the matter at WHO might meet the demands of social justice

Image
Business Standard
Last Updated : Dec 05 2017 | 10:46 PM IST
With reference to “How red tape over a dengue vaccine avoided a health crisis” by Abhineet Kumar & Veena Mani (December 5), to think that the World Health Organisation (WHO) — that “final arbiter in matters concerning global health” — goofed up would send shivers up anyone’s spine! The whole world, especially the developing countries, looks up to WHO for endorsement of new medicines, vaccines, national health care practices and disease eradication campaigns. Everyone considers its opinion and comments as the last word in matters concerning universal health. For WHO to have approved a mass vaccine, obviously without adequate testing, is nothing short of sacrilege; something that raises doubts, both about its impartiality as well as ability to pronounce decisions in matters of life and death.
 
Of course, all this does not in any way absolve Sanofi Pasteur, one of the largest and best known manufacturers of pharmaceutical products, from responsibility and the crisis caused in the Philippines. Its negligence has caused untold misery to 730,000 people, mostly children, who were administered the suspect vaccine. They are likely to suffer for no fault on their part, or even any that of their government. That country launched a huge immunisation campaign that hinged on a vaccine from a top manufacturer and carried the stamp of WHO approval. Many children would die. No amount of compensation from Sanofi can make up for the grievous harm done to the unsuspecting people.
 
Only a total ban on Sanofi and summary dismissal of all those concerned with the matter at WHO might meet the demands of social justice. India can only take sadistic and morbid pleasure in having avoided an even bigger disaster because our people sat on the case and the “red tape” kept the files tied shut! Krishan Kalra   Gurugram
Letters can be mailed, faxed or e-mailed to: The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg New Delhi 110 002
Fax: (011) 23720201  ·  E-mail: letters@bsmail.in
All letters must have a postal address and telephone number

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story